Effects of fluvastatin (XU 62-320), an HMG-CoA reductase inhibitor, on the distribution and composition of low density lipoprotein subspecies in humans

This publication has 10 references indexed in Scilit:

• Lipid Lowering Drugs in Atherosclerosis—the HMG-CoA Reductase Inhibitors
  Clinical and Experimental Hypertension. Part A: Theory and Practice, 1989
• HMG-CoA Reductase Inhibitors for Treatment of Hypercholesterolemia
  New England Journal of Medicine, 1988
• Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
  Archives of internal medicine (1960), 1988
• Effect of gender, age, and lipid status on low density lipoprotein subfraction distribution. Results from the Framingham Offspring Study.
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
• Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
  Journal of Clinical Investigation, 1986
• Consensus conference. Lowering blood cholesterol to prevent heart disease
  Published by American Medical Association (AMA) ,1985
• The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease
  JAMA, 1984
• An improved detection system applied to the study of serum lipoproteins after single-step density gradient ultracentrifugation
  Analytical Biochemistry, 1981
• Bile sequestrant therapy alters the compositions of low-density and high-density lipoproteins
  Metabolism, 1979
• The Ultracentrifugal Characterization and Isolation of Human Blood Lipids and Lipoproteins, with Applications to the Study of Atherosclerosis.
  The Journal of Physical Chemistry, 1951